Disclosure Of First-Time Adoption [Text Block]

BerGenBio - Filing #2581090

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
88,498,000 NOK
35,780,000 NOK
8,866,000 NOK
43,852,000 NOK
40,386,000 NOK
384,426,000 NOK
335,195,000 NOK
8,846,000 NOK
33,272,000 NOK
8,726,000 NOK
628,231,000 NOK
670,229,000 NOK
Comprehensive income
0 NOK
302,606,000 NOK
302,606,000 NOK
0 NOK
309,476,000 NOK
0 NOK
0 NOK
309,476,000 NOK
Profit (loss)
302,122,000 NOK
302,122,000 NOK
309,364,000 NOK
309,364,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.